Literature DB >> 15497385

Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-alpha.

Akira Yoshizu1, Yotaro Izumi, Sungick Park, Hiromi Sakai, Shinji Takeoka, Hirohisa Horinouchi, Eiji Ikeda, Eishun Tsuchida, Koichi Kobayashi.   

Abstract

It is known that damage to the intestinal mucosa followed by systemic inflammatory response is one of the leading causes of shock related morbidity and mortality. In this study, we examined the ability of an artificial oxygen carrier hemoglobin vesicle (HbV) to sustain systemic and intestinal perfusion during hemorrhagic shock. In rabbits, hemorrhagic shock (40% of the estimated blood volume) was resuscitated with 5% albumin (alb group), HbV suspended in 5% albumin (HbValb group), or washed red blood cells suspended in 5% albumin (RBCalb group). Plasma tumor necrosis factor (TNF)-alpha level was measured in rats under the same experimental protocol. No significant intergroup differences were seen in systemic hemodynamics. In contrast, parameters of intestinal perfusion significantly deteriorated in the alb group but were equally well sustained in the HbValb and RBCalb groups. Also, a significant increase in plasma TNF-alpha level was seen in the alb group but not in the RBCalb or HbValb groups. These results indicate the proficient oxygen transporting capability of HbV and its potential efficacy in shock resuscitation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497385     DOI: 10.1097/01.mat.0000136508.51676.ef

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  Magnetic resonance spectroscopy for evaluation of liposome-encapsulated hemoglobin as a resuscitation fluid.

Authors:  Vibhudutta Awasthi; H Agashe; S Doblas; R Towner
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2010-04

2.  Oxygen metabolism during cardiopulmonary bypass with hemodilution using liposome-encapsulated hemoglobin in kid goats.

Authors:  Rei Kansaku; Toshihide Mizuno; Eisuke Tatsumi; Yoshitaka Ogata; Takanobu Ishizuka; Yoshiyuki Taenaka
Journal:  J Artif Organs       Date:  2008-04-15       Impact factor: 1.731

Review 3.  Overview of Potential Clinical Applications of Hemoglobin Vesicles (HbV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium.

Authors:  Hiromi Sakai
Journal:  J Funct Biomater       Date:  2017-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.